glp-1 articles Drugs: 6 Things We've Learned About Their Effects Frontiers | GLP-1 receptor agonist

This action, called the incretin effect, accounts for as much as half of the postprandial insulin response and is exploited therapeutically for diabetes treatment through the use of incretin mimetic drugs and inhibitors of dipeptidyl peptidase 4, which degrades GLP-1

The risk of adverse event development depends on the prior therapy, the duration of the treatment, the form of the drug, and individual factors, i.e., BMI, genetics, and age

People may be more inclined to participate in cessation programs if they believe they can stop smoking without incurring the cost of putting on weight []

doi: 10.1007/s00125-012-2582-5

Supplementary Table 16 (download XLSX The predictions of multi-task neural-network model ensemble for glucagon-like peptide-1 orthologues sequences collected from the NCBI database

Ali: If surgery is not an option, we can try medications that stimulate more than one receptor (such as Zepbound) or a combination of different medications